This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Università Degli Studi Di Roma "La Sapienza", Universitá Degli Studi Di Siena. Active years: 2018.
Company Filing History:
1 out of 63 
1 out of 18 Years Active: 2018
Title: Sara Toscano: Innovator in Hedgehog Pathway Inhibition
Introduction
Sara Toscano is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of cancer research, particularly through her innovative work on Hedgehog pathway inhibitors. Her research focuses on developing compounds that can selectively inhibit the activity of the Hedgehog (Hh) pathway, which is crucial in treating Hh-dependent tumors.
Latest Patents
Sara Toscano holds a patent for her invention titled "Multitarget hedgehog pathway inhibitors and uses thereof." This patent concerns compounds that selectively inhibit the activity of the Hedgehog pathway. The compounds developed by Toscano are particularly useful in treating tumors such as medulloblastoma.
Career Highlights
Throughout her career, Toscano has been associated with prestigious institutions, including the Università Degli Studi Di Roma "La Sapienza" and the Università Degli Studi Di Siena. Her work has garnered attention for its potential impact on cancer treatment and research.
Collaborations
Sara Toscano has collaborated with notable colleagues in her field, including Bruno Botta and Alberto Gulino. These collaborations have contributed to the advancement of her research and the development of innovative solutions in cancer therapy.
Conclusion
Sara Toscano is a trailblazer in the field of cancer research, with her innovative patents and collaborations paving the way for new treatment options. Her work exemplifies the importance of innovation in addressing complex medical challenges.